Log in
Enquire now
‌

US Patent 9073943 Antiviral compounds with a dibenzooxaheterocycle moiety

Patent 9073943 was granted and assigned to Lupin Limited on July, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Lupin Limited
0
Current Assignee
‌
Lupin Limited
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
90739430
Patent Inventor Names
Rajender Kumar Kamboj0
Moloy Manoj Banerjee0
Vidya Ramdas0
Venkata P. Palle0
Advait Arun Joshi0
Amit Kumar Das0
Deepak Sahebrao Walke0
Date of Patent
July 7, 2015
0
Patent Application Number
143755340
Date Filed
February 8, 2013
0
Patent Primary Examiner
‌
Kristin Vajda
0
Patent abstract

Disclosed are compounds of formula (I) for use as antiviral agents, particularly as anti-hepatitis virus C agents, wherein R-R 6 and q are as described herein. Also disclosed are pharmaceutical compositions and methods of treating or preventing viral infection in a host by the use of these compounds, either alone or in combination with other pharmaceutically active agents. Further disclosed are methods of preparing such compounds. (I).

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9073943 Antiviral compounds with a dibenzooxaheterocycle moiety

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.